该产品产能充足,可稳定供货,已通过EU、CDE审评,已递交US。
海正药业是一家研产销全价值链齐备、多地域发展的综合性制药企业,拥有原料药三大生产基地,产线完善,覆盖近100个品种,是全球特色原料药重要生产企业之一。
海正药业装备有先进的生产设备设施及检测仪器,生产、检测及放行遵循GMP要求;海正药业在台州总部建有中央研究院,拥有国家认定的企业技术中心,省级院士工作站、省**具有独立招收资格的博士后科研工作站,研发平台建有研发实验室与中小规模的试制车间,为新产品、新工艺开发到产业化提供了无缝衔接。
海正药业配备专业的质量管理团队和完善的质量管理体系,覆盖药品质量的整个生命周期;
海正药业药政体系可高效能支持客户全球注册事务,为全球客户提供更好的产品和服务;
海正药业建立EHS实验室,配备专业的研究团队和先进的实验设备,完善的EHS综合管理体系和专业的EHS管理团队,为公司的安全生产、绿色发展保驾护航。该实验室管理体系于2018年通过了CNAS认证。
海正药业坚持“没有**好,只有更好”的发展理念,期盼与您携手并进!
西罗莫司CAS号:53123-88-9
西罗莫司分子式: C51H79NO13
西罗莫司英文名称: Sirolimus
西罗莫司英文同义词: Rapamycin; (-)-Rapamycin; (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl)-1-methylethyl)-10,21-imethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone; Antibiotic AY 22989; Rapammune; 23,27-Epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone, 9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-9,27-dihydroxy-3-(3-(4-hydroxy-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-, (3S-(3R*S*1R*,3S*,4S*)),6S*,7E,9S*,10S*,12S*,14R*,15E,17E,19E,21R*,23R*,26S*,27S*,34aR*))-; (3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone; (3S,6R,7E,9R,10R,12R,14S,15Z,17E,19E,21S,26R,27R,34aS)-9,27-dihydroxy-3-{(1R)-2-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethyl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone
西罗莫司分子量: 914.1719
西罗莫司沸点: 973°C at 760 mmHg
西罗莫司密度: 0mmHg at 25°C
西罗莫司闪点: 542.3°C